Ignite Creation Date:
2025-12-24 @ 5:06 PM
Ignite Modification Date:
2026-01-17 @ 2:25 AM
Study NCT ID:
NCT05859750
Status:
RECRUITING
Last Update Posted:
2024-12-16
First Post:
2023-04-14
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of AK104 With Chemotherapy as First-line Treatment in Patients With Advanced Pancreatic Cancer
Sponsor:
Akeso
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
AK104-217
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None